High materiality7/10
Morgan Stanley Starts IMAX Corporation (IMAX) at Overweight
Why it may matterVerify against the original reporting
Overweight
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley initiates coverage on IMAX with an Overweight rating and a $63 price target; current price is $53.30.
- IMAX upgraded to Overweight with a $63 target; current $53.30.
- Overweight rating with upside to $63.
Key facts
- 01
Target: $63
- 02
Posted price: $53.3
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Daniel Duran
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.